{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:00:33Z","timestamp":1782316833925,"version":"3.54.5"},"reference-count":25,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"unspecified","delay-in-days":51,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transthyretin amyloidosis is an under-recognised systemic disease whereby misfolded transthyretin proteins form fibrils capable of depositing in various tissues and organs. Despite improvements to diagnostic modalities, the associations between imaging techniques and clinical laboratory metrics remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-centre retrospective cohort study was performed including 183 patients aged 18 years or older diagnosed with transthyretin cardiac amyloidosis (ATTR-CA) in a tertiary care setting. Linear regression and multivariate proportional hazard models were used to examine the associations between established imaging modalities (ie, technetium-99m pyrophosphate (\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-PYP) scintigraphy and echocardiography) and cardiac biomarkers (ie, cardiac troponin I and B-type natriuretic peptide (BNP)). The study included patients who visited the Toronto General Hospital Peter Munk Cardiac Centre between October 2012 and December 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 183 patients included, 143 (78.1%) were male, with a median age (IQR) of 73.0 (66.0\u201379.0) years. Primary analyses revealed significant associations between positive\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-PYP grading and echocardiographic parameters, particularly increased left ventricular (LV) mass (\u03b2=111.21, p=0.009) and greater interventricular septal thickness at end-diastole (IVSd) (\u03b2=0.48, p=0.003) in patients with hereditary transthyretin amyloidosis (ATTRm). Additionally, positive\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-PYP grades correlated significantly with cardiac biomarkers, including log-transformed BNP (logBNP; \u03b2=1.99, p=0.002) in patients with ATTRm and log-transformed Troponin (logTroponin; \u03b2=1.68, p=0.007) in patients with wild type ATTR (ATTRwt). Conversely, the heart-to-contralateral lung ratio, a quantitative index derived from\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-PYP scintigraphy, did not show significant correlations with cardiac biomarkers (logBNP and logTroponin), but demonstrated significant associations with LV mass (\u03b2=134.52, p=0.001) and IVSd (\u03b2=0.46, p=0.002) in patients with ATTRm.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These data suggest strong associations exist between cardiac biomarkers, structural echocardiographic changes and\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-PYP scintigraphy, emphasising the importance of a multipronged diagnostic approach stratified by genotype.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2024-002686","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T10:30:15Z","timestamp":1755772215000},"page":"e002686","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Elucidating associations between technetium pyrophosphate scintigraphy, echocardiography and cardiac biomarkers in transthyretin cardiac amyloidosis"],"prefix":"10.1136","volume":"12","author":[{"given":"Bennett","family":"Di Giovanni","sequence":"first","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakota","family":"Gustafson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University School of Medicine, Kingston, Ontario, Canada"},{"name":"University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2169-3730","authenticated-orcid":false,"given":"Priya","family":"Arivalagan","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell B","family":"Adamson","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-7750","authenticated-orcid":false,"given":"Julie","family":"Vishram-Nielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Kobenhavn, Denmark"},{"name":"Division of Cardiology, Heart Failure, Heart Transplant, Toronto General Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Delgado","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada"},{"name":"University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"2026010701103859000_12.2.e002686.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)33478-3"},{"key":"2026010701103859000_12.2.e002686.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.67"},{"key":"2026010701103859000_12.2.e002686.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"2026010701103859000_12.2.e002686.4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/eurheartj\/ehae811","article-title":"Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine","volume":"46","author":"Gonzalez-Lopez","year":"2025","journal-title":"Eur Heart J"},{"key":"2026010701103859000_12.2.e002686.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.022"},{"key":"2026010701103859000_12.2.e002686.6","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac119"},{"key":"2026010701103859000_12.2.e002686.7","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000792"},{"key":"2026010701103859000_12.2.e002686.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"2026010701103859000_12.2.e002686.9","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead106","article-title":"Cardiac amyloidosis and aortic stenosis: a state-of-the-art review","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2026010701103859000_12.2.e002686.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.12.060"},{"key":"2026010701103859000_12.2.e002686.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2026010701103859000_12.2.e002686.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"2026010701103859000_12.2.e002686.13","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01760-6"},{"key":"2026010701103859000_12.2.e002686.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409134"},{"key":"2026010701103859000_12.2.e002686.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"2026010701103859000_12.2.e002686.16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild-Type Transthyretin Amyloid Cardiomyopathy","volume":"11","author":"Morioka","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010701103859000_12.2.e002686.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.247312"},{"key":"2026010701103859000_12.2.e002686.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"2026010701103859000_12.2.e002686.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2026010701103859000_12.2.e002686.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2026010701103859000_12.2.e002686.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-017-0376-0","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics","volume":"19","author":"Williams","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026010701103859000_12.2.e002686.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"2026010701103859000_12.2.e002686.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"2026010701103859000_12.2.e002686.24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026010701103859000_12.2.e002686.25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-002686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:10:46Z","timestamp":1767777046000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/openhrt-2024-002686"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-002686","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}